Peregrine Pharmaceuticals, Inc. - Investor Relations

Investor Relations

Peregrine Pharmaceuticals, Inc.	Corporate and Media Relations	Investors
14282 Franklin Avenue, Tustin, CA 92780 Phone: 714-508-6000 Fax: 714-838-5817	Linda Donaldson 14282 Franklin Avenue Tustin, CA 92780 Tel: 714-508-6067 Fax: 714-838-5817 pr@peregrineinc.com	GendeLLindheim BioCom Partners, LLC Barbara Lindheim 48 Wall Street, Suite 1100 New York, NY 10005 Tel: 212-918-4949 Tel: 800-987-8256

Featured Event

Nov 18, 2009
Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference

Nov 10, 2009
New Study in Clinical Cancer Research Shows Therapeutic Promise of Peregrine's Bavituximab With Radiation in a Lethal Brain Cancer Model

Dec 10, 2009 at 11:30 AM ET
Second Quarter Fiscal Year 2010 Financial Results Conference Call

NASDAQ:PPHM
$2.95 - 0.07

Nov 20, 2009
4:00 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.

Shareholder Tools